Since the potent role of UCP2-mediated metabolic reprogramming associated with cancer cell proliferation and immunity has been described above in different studies [32,34,111,114,117], UCP2 activators may represent a promising therapeutic strategy to simultaneous target different energetic pathways essential for tumor growth. Here, UCP2 is linked to cancer.